mail
editor@ajptr.com
whatsapp
9409046853
logo

American Journal of PharmTech Research

Resham Ingawale

Author Profile
1
Publications
1
Years Active
3
Collaborators
43
Citations

Publications by Resham Ingawale

1 publication found • Active 2024-2024

2024

1 publication

21- CFR: An Important Concept Of Pharma Industry

with Gaurav Kale, A. M. Bhagwat, Manish Pujari
12/1/2024

21 CFR is the code of federal Regulation. It is the regulation which gives by the USA/America for the pharma Industries. It is started in 1935 by the America’s 32nd President (Franklil. D. Roosevlt). It is very useful for pharma Industries in future for the Manufacturing processing packaging or holding of drug and finish pharmaceutical’s. It is the regulation for the food and drugs. This paper explores Title 21 of the Code of Federal Regulations (21 CFR), highlighting its essential role in regulating various aspects of the pharmaceutical industry in the United States. It emphasizes 21 CFR's impact on ensuring the safety, efficacy, and quality of pharmaceuticals and biologics. The paper also examines its relevance in modern regulatory practices and its global influence on regulatory compliance and good manufacturing practices (GMP).It will most useful guidelines for new Pharmacists. It is the future of the pharma Industries. Which is trying to get approval from USFDA?

Author Statistics
Total Publications:1
Years Active:1
First Publication:2024
Latest Publication:2024
Collaborators:3
Citations:43
Whatsapp